LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 47.59 | 21.74 | 4570 | 4492 | 1.0173 | 1.0045 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.56 | 21.74 | 804 | 4838 | 0.1662 | 0.5888 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.56 | 21.74 | 4517 | 4838 | 0.9335 | 0.9824 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.56 | 21.74 | 1 | 4838 | 0.0002 | -0.3262 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 49.56 | 21.74 | 4921 | 4838 | 1.0170 | 1.0043 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.53 | 21.74 | 908 | 5150 | 0.1763 | 0.6050 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.53 | 21.74 | 4925 | 5150 | 0.9562 | 0.9887 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.53 | 21.74 | 2 | 5150 | 0.0004 | -0.2610 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 51.53 | 21.74 | 5253 | 5150 | 1.0198 | 1.0050 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.50 | 21.74 | 1013 | 5425 | 0.1867 | 0.6200 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.50 | 21.74 | 5025 | 5425 | 0.9261 | 0.9808 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.50 | 21.74 | 1 | 5425 | 0.0002 | -0.3207 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 53.50 | 21.74 | 5651 | 5425 | 1.0415 | 1.0102 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 21.74 | 1142 | 5768 | 0.1980 | 0.6356 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 21.74 | 5427 | 5768 | 0.9408 | 0.9849 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 21.74 | 10 | 5768 | 0.0017 | -0.0919 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 55.48 | 21.74 | 6071 | 5768 | 1.0524 | 1.0127 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.45 | 21.74 | 1181 | 6023 | 0.1961 | 0.6362 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.45 | 21.74 | 5756 | 6023 | 0.9556 | 0.9888 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.45 | 21.74 | 10 | 6023 | 0.0017 | -0.0913 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 57.45 | 21.74 | 6652 | 6023 | 1.1043 | 1.0246 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.42 | 21.74 | 1308 | 6125 | 0.2135 | 0.6544 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.42 | 21.74 | 6138 | 6125 | 1.0021 | 1.0005 | MN20160310_N01 | C22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.42 | 21.74 | 5 | 6125 | 0.0008 | -0.1652 | MN20160310_N01 | G16 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.018333 | 59.42 | 21.74 | 7031 | 6125 | 1.1479 | 1.0342 | MN20160310_N01 | G16 |